Rallybio
RLYB15.9300.87% ( -0.140 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Rallybio(RLYB) predict that the Revenue is 212 K (+0%), Beat estimate;the EPS is -1.46 (+13.1%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.00B--
0.00B100.00%
+0.00B100.00%
EPSMiss expectations
-1.4613.10%
-1.228.57%
-0.260015.47%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf